CORTELLARO, MICHELE
 Distribuzione geografica
Continente #
EU - Europa 5.307
NA - Nord America 4.232
AS - Asia 3.760
SA - Sud America 388
AF - Africa 108
OC - Oceania 8
Continente sconosciuto - Info sul continente non disponibili 2
Totale 13.805
Nazione #
US - Stati Uniti d'America 4.093
GB - Regno Unito 1.800
CN - Cina 1.239
SG - Singapore 1.141
IT - Italia 872
SE - Svezia 627
DE - Germania 508
RU - Federazione Russa 414
HK - Hong Kong 269
BR - Brasile 265
UA - Ucraina 262
VN - Vietnam 245
FR - Francia 235
IN - India 234
NL - Olanda 168
KR - Corea 141
TR - Turchia 134
BD - Bangladesh 131
IE - Irlanda 127
EU - Europa 117
CA - Canada 104
FI - Finlandia 102
CO - Colombia 59
PL - Polonia 53
JP - Giappone 44
CI - Costa d'Avorio 43
ID - Indonesia 39
BE - Belgio 23
AR - Argentina 21
IQ - Iraq 20
ZA - Sudafrica 20
ES - Italia 18
PK - Pakistan 18
MX - Messico 17
DK - Danimarca 16
EC - Ecuador 15
GR - Grecia 14
SA - Arabia Saudita 14
UZ - Uzbekistan 13
MY - Malesia 12
AT - Austria 11
IL - Israele 11
VE - Venezuela 11
PT - Portogallo 8
AE - Emirati Arabi Uniti 7
AL - Albania 7
AZ - Azerbaigian 7
CL - Cile 7
ET - Etiopia 7
MA - Marocco 7
RO - Romania 7
AU - Australia 6
KG - Kirghizistan 6
LU - Lussemburgo 6
SI - Slovenia 6
BG - Bulgaria 5
CH - Svizzera 5
IR - Iran 5
KZ - Kazakistan 5
DZ - Algeria 4
EG - Egitto 4
JM - Giamaica 4
KE - Kenya 4
PE - Perù 4
UY - Uruguay 4
JO - Giordania 3
LT - Lituania 3
NP - Nepal 3
PA - Panama 3
PH - Filippine 3
TN - Tunisia 3
ZM - Zambia 3
BO - Bolivia 2
CR - Costa Rica 2
CZ - Repubblica Ceca 2
LB - Libano 2
LK - Sri Lanka 2
ML - Mali 2
MU - Mauritius 2
MW - Malawi 2
NZ - Nuova Zelanda 2
OM - Oman 2
PS - Palestinian Territory 2
SN - Senegal 2
TH - Thailandia 2
AM - Armenia 1
AO - Angola 1
BB - Barbados 1
BH - Bahrain 1
BN - Brunei Darussalam 1
BS - Bahamas 1
BW - Botswana 1
BY - Bielorussia 1
CM - Camerun 1
DO - Repubblica Dominicana 1
EE - Estonia 1
GA - Gabon 1
GP - Guadalupe 1
GT - Guatemala 1
HN - Honduras 1
Totale 13.907
Città #
Southend 1.631
Singapore 592
Ashburn 403
Chandler 378
Beijing 309
San Jose 290
Hong Kong 244
Seattle 218
Jacksonville 215
Milan 194
Princeton 159
Wilmington 139
Dublin 124
Santa Clara 118
Mountain View 112
Council Bluffs 107
Ann Arbor 98
Los Angeles 96
Nanjing 96
Redmond 95
Bengaluru 93
Boardman 93
Woodbridge 89
Fairfield 85
Frankfurt am Main 82
New York 79
Dallas 78
Dearborn 74
Ho Chi Minh City 74
Lauterbourg 66
Sakarya 66
Toronto 60
Andover 58
Des Moines 57
Serra 57
Margão 56
Bogotá 52
Hanoi 49
Guangzhou 48
Somerville 48
Buffalo 47
Munich 46
Houston 44
Abidjan 43
Shanghai 43
Warsaw 43
Moscow 42
Nanchang 42
Hefei 38
Cambridge 37
Tokyo 37
Turin 34
Shenyang 32
Hangzhou 30
Jinan 30
Rome 30
Helsinki 28
Grafing 27
Columbus 26
Brussels 22
Tianjin 22
Phoenix 21
Berlin 20
Jakarta 20
Hanover 18
Ottawa 18
Medford 17
Dong Ket 16
Auburn Hills 15
Cangzhou 15
Changsha 15
Athens 14
Da Nang 14
Hebei 14
Johannesburg 14
Shenzhen 14
São Paulo 14
The Dalles 14
Verona 14
Bitonto 13
Chicago 13
Jiaxing 13
Redwood City 13
Wuhan 13
Atlanta 12
Eitensheim 12
Kunming 12
Kwai Chung 12
Roubaix 11
Roxbury 11
Bari 10
Fuzhou 10
Haiphong 10
Quanzhou 10
Taizhou 10
Zhengzhou 10
Belo Horizonte 9
Bologna 9
Brooklyn 9
Chennai 9
Totale 8.243
Nome #
Un caso di dolore osteo-muscolare non responsivo ai FANS 404
Adherence to antibiotic treatment guidelines and outcomes in the hospitalized elderly with different types of pneumonia 355
Calo ponderale e leucocitosi: quale la causa? 333
Are pleiotropic effects of statins real? 294
The MIAMI Study (Markers of inflammation and Atorvastatin effect in previous myocardial infarction) : results of a prospective, multicenter study 276
E-selectin and TFPI are associated with carotid intima-media thickness in stable IHD patients : the baseline findings of the MIAMI study 274
Esordio tipico di emorragia cerebrale atipica 269
Anemia emolitica: malattia o epifenomeno? 248
The MIAMI study (Markers of Inflammation and Atorvastatin effect in previous Myocardial Infarction): results of a prospective, open-label, multicenter study 244
Increased fibrin turnover and high PAI-1 activity as predictors of ischemic events in atherosclerotic patients. A case-control study 242
Relation between hemostatic variables and increase of common carotid intima-media thickness in patients with peripheral arterial disease 242
The PLAT Study : a multidisciplinary study of hemostatic function and conventional risk factors in vascular disease patients 240
Association of increased fibrin turnover and defective fibrinolytic capacity with leg atherosclerosis. The PLAT Group 239
Danno d’organo subclinico in una popolazione sovrappeso/obesa a rischio cardiovascolare intermedio 238
The MIAMI Study (Markers of inflammation and Atorvastatin effect in previous myocardial infarction): Results of a prospective, open-label, multicenter Study. 237
Increased fibrin turnover and high PAI-1 activity as predictors of ischemic events in atherosclerotic patients. A case-control study. The PLAT Group 235
Progetto innovativo per migliorare la qualità della prevenzione cardio-cerebrovascolare attraverso un modello di integrazione Ospedale-Territorio e la valutazione di parametri non compresi nella definizione del rischio intermedio – Progetto CAPRESS 234
Inflammatory Markers and Carotid Intima Media Thickness (C-IMT) in Stable IHD Patients 233
Relationship between haemostatic variables and the progression of carotid atherosclerosis 232
Psicosi acuta ed epilessia: quale alterazione metabolica 230
Hemostatic variables and progression of common carotid intima-media thickness in patients with peripheral arterial disease 224
Un caso da manuale 219
Markers of inflammation, thrombosis and endothelial activation correlate with carotid IMT regression in stable coronary disease after atorvastatin treatment 219
The PLAT Study: hemostatic function in relation to atherothrombotic ischemic events in vascular disease patients. Principal results. PLAT Study Group. Progetto Lombardo Atero-Trombosi (PLAT) Study Group 217
Atorvastatin and thrombogenicity of the carotid atherosclerotic plaque: the ATROCAP study 217
Regression of severe atherosclerotic lesions after vitamin replacement in hyperhomocysteinemia with multiple heterozygous mutations 216
The ATROCAP Study: atorvastatin and the thrombogenicity of carotid atherosclerotic plaque 213
Target organ damage in a population at intermediate cardiovascular risk, with adjunctive major risk factors : CArdiovascular PREvention Sacco Study (CAPRESS) 211
The PLAT Study : hemostatic function in relation to atherothrombotic ischemic events in vascular disease patients. Principal results. PLAT Study Group Progetto Lombardo Atero-Trombosi (PLAT) Study Group 209
Effetti di Atorvastatina su markers solubili aterosclerosi carotidea : Risultati dello Studio MIAMI 208
Subclinical disease (SD) in overweight and obese individuals at intermediate cardiovascular (CV) risk 203
Target organ damage in an asymptomatic population at intermediate cardiovascular risk and adjunctive major risk factors : the cardiovascular prevention Sacco study (CAPRESS) 202
E-Selettina e l’inibitore del fattore tissutale (TFPI) correlano con l’inspessimento medio-intimale carotideo (C-IMT) in pazienti con malattia ischemica coronarica in fase di stabilità clinica: risultati basali dello Studio MIAMI 196
A case of multiorgan atherosclerotic disease in patient affected by hyperhomocistinemia with multiple heterozigous muattions 186
Cirrosi biliare primitiva ama negativa esordita con grave osteoporosi 184
Arteriosclerosi e suscettibilità d'organo 183
Beneficial effects of fluvastatin following percutaneous coronary intervention in patients with unstable and stable angina : results from the Lescol Intervention Prevention Study (LIPS) 181
Come migliorare la stratificazione del rischio intermedio 181
E-selectin and TFPI are associated with carotid intima-media thickness in stable coronary patients : the baseline findings of the MIAMI Study 180
Regression of severe atherosclerotic lesions after vitamin replacement in hyperhomocysteinemia with multiple heterozygous mutations 180
Soluble E-Selectin and tissue factor pathway inhibitor, but not C-reactive protein, correlate with carotid intima-media thickness (C-IMT) in stable coronary patients: the baseline data of the MIAMI Study 178
Atherosclerotic plaque as a therapeutic target. The ATROCAP Study (Atorvastatin and Thrombogenicity of Carotid Atherosclerotic Plaque). 178
Long-term fluvastatin reduces the hazardous effect of renal impairment on four-year atherosclerotic outcomes (a LIPS substudy) 176
Performance of PSI, CURB-65, and SCAP scores in predicting the outcome of patients with community-acquired and healthcare-associated pneumonia 169
Relazione tra variabili emostatiche e modificazioni dell'ispessimento intimale della carotide in pazienti con malattia ischemica periferica 168
Markers of hemostatic system activation during thromboprophylaxis with recombinant hirudin in total hip replacement 165
Relation between hemostatic variables and changes of carotid intima-media thickness in PAD patients 165
Inibitori della COX-2: una promessa non mantenuta? Il parere dell'internista 163
Progetti regionali innovativi area cardiocerebrovascolare 162
Effect of atorvastatin on coagulation and inflammatory variables in patients with bilateral carotid stenosis. 160
null 159
Polineuropatia sensitivo-motoria acuta e febbre : un caso di panarterite 158
Valutazione della lesione d'organo subclinica nei soggetti a rischio cardiovascolare intermedio: un progetto di intehgrazione ospedale-territorio 156
Dermatan sulphate for the treatment of disseminated intravascular coagulation (DIC) in acute leukemia: a randomised, heparin-controlled pilot study 156
Picotamide, a combined inhibitor of thromboxane A2 synthase and receptor, reduces 2-year mortality in diabetics with peripheral arterial disease : the DAVID study 155
Inflammatory Markers and C-IMT in Patients with Previous Myocardial Infarction. The Atorvastatin Effect . MIAMI Study 150
Idarubicin plus cytarabine as first-line treatment of acute nonlymphoblastic leukemia 145
Idarubicin in the therapy of acute myeloid leukemia : final analysis in 57 previously untreated patients 144
Does the metabolic syndrome predict subclinical atherosclerotic damage in an asymptomatic population at intermediate cardiovascular risk? 140
The regression between multiple inflammatory markers and C-IMT in normocholesterolemic stable IHD. The effect of moderate dose of atorvastatina (MIAMI study) 138
Dai grandi trials alla pratica clinica: l’esempio delle statine 137
Dermatan sulphate in acute leukaemia 137
Markers infiammatori solubili ed evoluzione della placca aterosclerotica : effetto del trattamento con statina a dosi moderate in pazienti con cardiopatia ischemica stabile : studio MIAMI 136
The antiatherothrombotic effects of Atorvastatin : the ATROCAP Study results 136
Fibrinolytic variables in prediction of atherothrombotic sequelae in patients with preexisting vascular ischaemic disease : the plat study 135
Un insolito caso di malassorbimento 133
Fibrinolytic variables in atherosclerotic patients-comparison between patients with and without peripheral arterial-disease (PAD) 133
Esiste realmente l'effetto antinfiammatorio delle statine? 131
Switching statins : an appropriate guideline for clinical practice? 128
Flogosi granulomatosa polmonare in B-LLC trattata con fludarabina 128
Antiatherosclerotic and antiatherothrombotic effects of statins 127
Placca o individuo a rischio? 126
Biomarkers ed evoluzione della placca 118
Progetto pilota di collaborazione tra medici di medicina generale e ospedale per migliorare la valutazione del rischio cardiovascolare in soggetti a rischio intermedio. 114
Inflammatory markers and C-IMT in patients with previous myocardial infarction. The atorvastatin effect. MIAMI Study 97
FVIII-C-VWF-AG, fibrinogen, PAI-1 and leukocytes are associated with ischemic events in vascular-disease patients : the plat study 93
null 4
Totale 14.526
Categoria #
all - tutte 34.972
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 34.972


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202170 0 0 0 0 0 0 0 0 0 0 0 70
2021/2022804 90 28 27 41 33 58 83 49 90 51 72 182
2022/20231.238 150 152 112 144 154 226 26 71 139 4 47 13
2023/2024631 20 53 45 35 142 70 11 64 14 19 80 78
2024/20251.865 76 147 19 186 165 90 71 154 117 154 106 580
2025/20263.558 389 201 284 331 314 265 462 158 418 345 270 121
Totale 14.526